GLG Network Survey: US & European Telemedicine

Please complete the form below to request access to the survey data.



The GLG Survey team interviewed 50 general practitioners, cardiologists, gastroenterologists, endocrinologists, dermatologists, and OBGYNs across the US and Europe.

What will you learn from this survey?

  • Current general practitioners, cardiologists, gastroenterologists, endocrinologists, dermatologists, and OBGYNs shared trends in current telemedicine usage at their practices.
  • The survey investigates the impact COVID-19 has had on the telemedicine market as well as both short- and long-term trends likely to persist after the pandemic.
  • Additionally, the survey explores telemedicine reimbursement rates.


The GLG Survey team drafted the questionnaire with the support of GLG Council Member, Nirmal Patel, former CMO/VP of Population Health at United Health Group Incorporated and former SMIO at Teledoc.

The standard deliverable, includes:

  • 1 x Individual responses (“raw data”), in Excel.
  • 1 x PPT report with aggregated data.


This survey is available to subscribers of the Healthcare (HC) sector (Limited subscriptions and above).

  • For those with a subscription not including the above, cost of the survey is $7,000 USD. This offer includes the raw data file and a high-level presentation through PowerPoint.
  • A more detailed set of cross-tabulation tables (i.e. comparison of the data in different segmentation groups such as country and medical specialty, etc.) will be provided upon request for an additional charge of $1,500 USD.


Request other available and upcoming Network Surveys within the sector:


  • Audiologists
    • 100 audiologists provide an update on the hearing aid market and impact of COVID-19.
    • Questionnaire was drafted by the Owner of Cadence Hearing Services.
  • US Hospitals
    • 200+ Hospital C-suite level executives, procurement executives and healthcare physicians share their views on the impact of COVID-19 on various aspects of the hospital system.
    • Questionnaire was drafted by the former EVP Northern Region at Westchester Medical Center Health System.
  • Plasma Industry (upcoming)
    • 35 plasma collection centre operations managers will comment upon any changes in their daily activity as well as comment on future collection volumes in the next few months.
    • Questionnaire was drafted by the former Director/Head of Global Medical Affairs Specialty Products at Csl Behring.
  • Trodelvy (Cancer Treatment) (upcoming)
    • 30 breast, urothelial and lung cancer doctors in the US to comment on the market size of Trodelvy as a breast cancer treatment, whether doctors prescribe it, what they use it for, feedback from patients, usage trends since they have started prescribing it .
    • Questionnaire was drafted by current Professor of Medicine, Division of Medical Oncology, at Columbia University.



By downloading this document and/or participating in the Network Survey, you understand and agree that the information and material provided by GLG, including survey results and survey proposal information, is provided for your own insight and informational purposes only. You further acknowledge and agree that this is a Network Survey for multiple GLG clients, and the results will be provided to all GLG clients that agree to participate in the Network Survey and GLG clients that agree to purchase the Survey results in the future. All survey results do not constitute investment advice or a recommendation. In using this Survey, you agree to hold Gerson Lehrman Group and the Survey respondents harmless and free of all liability as a result of your use of this Network Survey, other than liability resulting from the gross negligence or wilful misconduct of the protected party. You otherwise agree to be bound by Gerson Lehrman Group’s Usage Policies in your interactions with Gerson Lehrman Group and your receipt of services. These Survey results are for are for client’s own use and client shall not redistribute, disseminate, publish, or display the same, in whole or in part, to any third parties or publicly without the prior written permission of Gerson Lehrman Group, except explicitly set forth in your agreement with GLG. This survey will be double-blinded to both client and respondent. GLG reserves the right to restrict the number of clients that can pre-commit access. These Network Surveys are priced outside of standard GLG subscriptions but at a substantially reduced price to commissioning a fully proprietary GLG Network Survey. Upon finding these terms acceptable, please send an affirmative confirmation via email, which GLG will file in its records. Once confirmed, please note that the Client’s agreement to purchase the Network Survey is a legally binding and irrevocable commitment. If the survey is not included within your subscription, GLG will invoice Client for the fees due for the Network Survey. Please note that some respondents may not be Council Members, and the Terms and Conditions of Council Membership would not apply to such respondents and detailed records for them will not be available aside from the information that GLG capture in the Network Survey.


Request Access

Thank you for your submission! A GLG representative will reach out to you.